In Genome Biology this week: parainflammation found in some cancers, recurrent copy number changes affecting metabolic genes in cancer, and more.
In blood samples from infected individuals, a seven-gene signature apparently distinguishes between bacterial and viral culprits, a distinction important to antibiotic use.
The company's approach investigates the utility of high-density lipoproteins as molecular markers for multiple diseases, starting with cardiovascular.
The genetic testing firm is developing a plan to drive market adoption of its PerioPredict test for inflammation-related genes.
The FDA considers Interleukin Genetics' PerioPredict test and the DNA-CardioCheck test to be medical devices.
Researchers link personality traits to the expression of certain inflammation-related genes.
The project will include the development of mass spec tools for studying systems-level protein-protein interactions.
Anagnostics aims to include the marker in a new version of its Hybcell Inflammation integrated sepsis monitoring test.
The five new grants, part of the Genomics of Gene Regulation program, will fund research into the mechanisms controlling gene expression.
NEW YORK (GenomeWeb News) – The Forsyth Institute plans to use a $4.1 million grant from the Massachusetts Life Sciences Center (MLSC) to create a new center that will develop saliva-based molecular diagnostic tests for assessing disease risk.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.
Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.
In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.
Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.